Literature DB >> 12004998

Assessing the clinical significance of single items relative to summated scores.

Jeff A Sloan1, Neil Aaronson, Joseph C Cappelleri, Diane L Fairclough, Claudette Varricchio.   

Abstract

How many items are needed to measure an individual's quality of life (QOL)? This article describes the strengths and weaknesses of single items and summated scores (from multiple items) as QOL measures. We also address the use of single global measures vs multiple subindices as measures of QOL. The primary themes that recur throughout this article are the relationships between well-defined research objectives, the research setting, and the choice single item vs summated scores to measure QOL. The conceptual framework of the study, the conceptual fit with the measure, and the purpose of the assessment should all be considered when choosing a measure of QOL. No "gold standard" QOL measure can be recommended because no "one size fits all." Single items have the advantage of simplicity at the cost of detail. Multiple-item indices have the advantage of providing a complete profile of QOL component constructs at the cost of increased burden and of asking potentially irrelevant questions. The 2 types of indices are not mutually exclusive and can be used together in a single research study or in the clinical setting.

Entities:  

Mesh:

Year:  2002        PMID: 12004998

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  87 in total

1.  Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life?

Authors:  A G E M de Boer; J J B van Lanschot; P F M Stalmeier; J W van Sandick; J B F Hulscher; J C J M de Haes; M A G Sprangers
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

Review 2.  Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D.

Authors:  Stephen J Walters; John E Brazier
Journal:  Qual Life Res       Date:  2005-08       Impact factor: 4.147

Review 3.  The clinical significance of quality of life assessments in oncology: a summary for clinicians.

Authors:  Jeff A Sloan; Marlene H Frost; Rick Berzon; Amylou Dueck; Gordon Guyatt; Carol Moinpour; Mirjam Sprangers; Carol Ferrans; David Cella
Journal:  Support Care Cancer       Date:  2006-06-23       Impact factor: 3.603

4.  Placing quality of life assessments on oncologists' agenda.

Authors:  Luzia Travado
Journal:  Support Care Cancer       Date:  2006-08-26       Impact factor: 3.603

5.  Assessing measurement properties of two single-item general health measures.

Authors:  Karen B DeSalvo; William P Fisher; Ky Tran; Nicole Bloser; William Merrill; John Peabody
Journal:  Qual Life Res       Date:  2006-03       Impact factor: 4.147

6.  The effect of OPC Factor on energy levels in healthy adults ages 45-65: a phase IIb randomized controlled trial.

Authors:  Patrick J LaRiccia; John T Farrar; Mary D Sammel; Joseph J Gallo
Journal:  J Altern Complement Med       Date:  2008-07       Impact factor: 2.579

7.  A randomised trial of electro-acupuncture for arthralgia related to aromatase inhibitor use.

Authors:  Jun J Mao; Sharon X Xie; John T Farrar; Carrie T Stricker; Marjorie A Bowman; Deborah Bruner; Angela DeMichele
Journal:  Eur J Cancer       Date:  2013-10-24       Impact factor: 9.162

Review 8.  Capturing and Incorporating Patient-Reported Outcomes into Clinical Trials: Practical Considerations for Clinicians.

Authors:  Juliana Perez Botero; Gita Thanarajasingam; Rahma Warsame
Journal:  Curr Oncol Rep       Date:  2016-10       Impact factor: 5.075

9.  Spiritual well-being in lung cancer survivors.

Authors:  Marlene H Frost; Paul J Novotny; Mary E Johnson; Matthew M Clark; Jeff A Sloan; Ping Yang
Journal:  Support Care Cancer       Date:  2013-02-19       Impact factor: 3.603

10.  Overall survival and self-reported fatigue in patients with esophageal cancer.

Authors:  M C Stauder; Y Romero; B Kabat; P J Atherton; D Geno; C Deschamps; A Jatoi; J A Sloan; M Botros; K W Jung; A S Arora; R C Miller
Journal:  Support Care Cancer       Date:  2012-07-29       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.